Skip to content
Review Open access

Pharmacogenomics and Personalized Drug Therapy: Advances in Genetic Variants, Drug Response Prediction, and Precision Medicine

Oct 2026 · International Journal of Advanced Pharmaceutical Sciences and Research · Vol 6, pp. 15-22 · 0 citations · 27 references

TL;DR

The scientific and regulatory foundation for pharmacogenomic informed prescribing is developing, but translating it into routine use worldwide remains an unfinished agenda that will require coordinated clinical, informatics, and policy action.

Abstract

The study of individual drug response due to genetic variation, known as Pharmacogenomics (PGx), has transitioned from a research concept to become a key component of precision medicine in the clinic. New advances in genetic research have led to the identification of variants of cytochrome P450 metabolising enzymes (such as CYP2D6, CYP2C19, CYP2C9) and drug transporters (SLCO1B1), and human leukocyte antigen (HLA) genes, which account for much of the inter-individual differences in efficacy and toxicity of commonly used drug classes including antiplatelets, anticoagulants, antidepressants, statins, and chemotherapeutic drugs. This review collates recent literature (2020-2025) on three interwoven themes: (i) clinically actionable genetic variants and guidance for their use in consortia, such as the Clinical Pharmacogenetics Implementation Consortium (CPIC); (ii) the progression of drug response prediction, from rule-based algorithms through regression-based dosing models to novel machine learning and deep learning approaches incorporating multi-omics data; and (iii) the implementation of precision medicine, such as embedding clinical decision support in electronic health records (EHRs), establishing preemptive testing programmes, and the ongoing challenges of ancestral diversity, cost-effectiveness, and workforce education. We include a summary table of representative drug-gene pairs, a methodological comparison table, and an implementation efforts table, along with four figures visualising the PGx prescribing workflow, cytochrome P450 metabolizer phenotypes, an artificial intelligence approach to the prediction pipeline, and global disparities in pharmacogenomic representation. We believe the scientific and regulatory foundation for pharmacogenomic informed prescribing is developing, but translating it into routine use worldwide remains an unfinished agenda that will require coordinated clinical, informatics, and policy action.

Read PDF

Similar papers

Review Open access Sep 2026

Clinical Pharmacogenomics: Translating Genetic Variation into Individualized Drug Therapy

Clinical pharmacogenomics (PGx) is an emerging component of precision medicine that examines how inherited genetic variation influences an individual's response to medicines. Genetic differences affecting drug-metabolizing enzymes, transporters, receptors, immune pathways and therapeutic targets can contribute to inter...

Kalyani R · 0 citations
Review Open access Oct 2026

PHARMACOGENOMIC INSIGHTS INTO PERSONALIZED DRUG THERAPY: INTEGRATING MOLECULAR GENETICS AND PRECISION MEDICINE FOR IMPROVED CLINICAL OUTCOMES

The molecular and genetic basis of pharmacogenomic variability, clinically relevant biomarkers, enabling technologies, therapeutic applications, implementation pathways, and implications for clinical outcomes will be explored.

Swathi Ratnam Regidi, Surabhi Johari, Sanskar Singh et al. · 0 citations
Review Oct 2026

From CYP450 pharmacogenomics to personalized medicine: clinical evidence, dosing guidelines, and future perspectives.

Interindividual variability in drug response remains a critical challenge in contemporary pharmacotherapy, and cytochrome P450 (CYP450) genetic polymorphisms are a principal determinant of this heterogeneity. The CYP450 superfamily mediates the oxidative biotransformation of 70-80% of clinically prescribed medications....

K. Aldossary, Dalia K. Zaafar, Nada A. Alsaleh et al. · 0 citations
Review Oct 2026

Pharmacogenetics in HIV therapy: a review of key biomarkers, regulatory annotations, and clinical dosing guidelines.

INTRODUCTION Pharmacogenetics is pivotal in modern HIV management, facilitating the transition from the traditional "one-size-fits-all" model toward personalized precision medicine. By analyzing how unique genetic profiles influence pharmacological responses, clinicians can maximize therapeutic efficacy while minimizin...

Rita Nogueiras-Álvarez · 0 citations
Review Open access Oct 2026

The potential role of large language models in addressing phenoconversion in pharmacogenomics

Pharmacogenomics (PGx) is a cornerstone of precision medicine, enabling individualized drug therapy by identifying genetic factors that influence drug disposition and response. However, genotype-based predictions frequently fail to reflect actual drug-metabolizing capacity because enzyme activity can be modified by non...

Augusto Garcia-Agundez, José A. G. Agúndez · 0 citations
Review Open access Oct 2026

Can pharmacogenomics transform personalized medicine into routine clinical practice? Current evidence and future directions

The role of predictive biomarkers and pharmacogenomic profiling in addressing heterogeneity in treatment response, facilitating individualized therapeutic strategies, and improving clinical outcomes is emphasized.

R. Shinde, Janhavi Nimbalkar · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.